Skip to main content

Table 6 Uterine fibroid symptom severity (UFS-QoL) overall summary

From: The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China

    Months post treatment
UFS-QoL parameter Statistic Screening
(N = 107)
1
(N = 107)
3
(N = 102)
6
(N = 100)
SSS transformeda
  Mean (SD) 34.4 (14.70) 28.1 (15.00) 27.2 (15.70) 24 (16.10)
  95 % CI (31.6, 37.2) (25.2, 30.9) (24.2, 30.3) (20.8, 27.2)
HRQL transformeda
  Mean (SD) 73 (18.80) 78.1 (18.00) 78.5 (19.50) 82.2 (17.30)
  95 % CI (69.4, 76.6) (74.7, 81.6) (74.7, 82.4) (78.7, 85.6)
Total score
  Mean (SD) 79.3 (25.10) 71.3 (24.40) 70.6 (26.10) 65.4 (24.30)
  95 % CI (74.5, 84.1) (66.7, 76) (65.5, 75.7) (60.5, 70.2)
  1. SSS symptom severity score, HRQL health-related quality of life
  2. aTransformed scores (SSS and HRQL) can range from 0 to 100. The total score ranges from 37 to a maximum of 185